HIGHFDA DEVICE

Diagnostica Stago STA Liatest D-Di Recall 12,740 Units Worldwide in 2025

Diagnostica Stago recalled 12,740 STA Liatest D-Di units distributed worldwide after a potential risk of underestimating D-Dimer levels. The two listed lots may produce falsely low results. Stop using the devices immediately and follow recall instructions from Diagnostica Stago or your healthcare provider.

Official notice
Diagnostica StagoHealth & Personal CareMedical DevicesREF: 00515UDI-DI: 03607450005158Lot numbers: 271382

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
September 12, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
September 12, 2025
Hazard Level
HIGH
Brand
Diagnostica Stago
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Diagnostica Stago
Product type
D-Dimer immunoassay kit
Model numbers
REF: 00515, UDI-DI: 03607450005158, Lot numbers: 271382, 271411, Expiration 09/30/2025
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    September 12, 2025

  2. Reported by FDA DEVICE

    October 22, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

A potential risk of underestimation of D-Dimer (D-Di) levels with the two listed lots.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Diagnostica Stago, Inc. or your healthcare provider for instructions. Notification method: E-Mail

About This Product

D-Dimer immunoassays are used in clinical laboratories to help assess thrombotic risk in patients. The STA Liatest D-Di kit is part of this testing family. The recall concerns two lots with potential underestimation risk.

Why This Is Dangerous

If D-Dimer levels are underestimated, clinicians may misinterpret results, potentially delaying diagnosis and treatment of blood clots.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

Hospitals and labs using affected lots may need to retest patient samples if results were impacted. The issue could affect diagnostic decisions and patient safety.

Practical Guidance

How to identify if yours is affected

  1. Check lot numbers 271382 or 271411
  2. Confirm expiration date 2025-09-30
  3. If affected, stop using the kit immediately

Where to find product info

FDA recall page referenced in the notice; manufacturer instructions also apply

What timeline to expect

Timelines for refunds or replacements are not specified in the notice; contact Diagnostica Stago for details

If the manufacturer is unresponsive

  • Document all communications with Diagnostica Stago
  • If the company is unresponsive, file a report with the FDA recall process or seek guidance from your institution's risk department

How to prevent similar issues

  • Verify lot numbers and expiration date before use in any lot of D-Dimer testing kits
  • Maintain a strict recall check workflow for all laboratory reagents
  • Consider alternative D-Dimer testing platforms from other manufacturers if needed
  • Regularly review FDA recall notices and vendor alerts

Documentation advice

Keep the recall notice, verify lot numbers, retain all packaging and labeling, photograph lot/expiry codes, document testing impact and communications with the manufacturer

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Brand: Diagnostica Stago Product: STA Liatest D-Di Reference: REF 00515 UDI-DI: 03607450005158 Lot numbers: 271382, 271411 Expiration: 2025-09-30 Quantity: 12,740 units Sold worldwide, including US nationwide and Canada Recall status: ACTIVE Recall date: 2025-09-12 Report date: 2025-10-22

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • Lot numbers 271382 and 271411
  • Worldwide distribution (US nationwide and Canada)
  • Stop use immediately; follow recall instructions

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
REF: 00515
UDI-DI: 03607450005158
Lot numbers: 271382
271411
Expiration 09/30/2025
Affected States
ALL
Report Date
October 22, 2025
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more